Use of Opioid Analgesics in Patients With Chronic Low Back Pain and Knee Osteoarthritis.

Am J Phys Med Rehabil

Department of Physical Medicine and Rehabilitation Sunrise Health GME Consortium Las Vegas, Nevada. Department of Physical Medicine and RehabilitationMontefiore Medical Center Albert Einstein College of Medicine Bronx, New York. Department of Physical Medicine and RehabilitationIcahn School of Medicine at Mount Sinai New York, New York Department of Physical Medicine and Rehabilitation Montefiore Medical Center Albert Einstein College of Medicine Bronx, New York.

Published: August 2019

Download full-text PDF

Source
http://dx.doi.org/10.1097/PHM.0000000000001109DOI Listing

Publication Analysis

Top Keywords

opioid analgesics
4
analgesics patients
4
patients chronic
4
chronic low
4
low pain
4
pain knee
4
knee osteoarthritis
4
opioid
1
patients
1
chronic
1

Similar Publications

Background: To provide recommendations on risk mitigation, diagnosis and treatment of infectious complications associated with the practice of regional anesthesia, acute and chronic pain management.

Methods: Following board approval, in 2020 the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) commissioned evidence-based guidelines for best practices for infection control. More than 80 research questions were developed and literature searches undertaken by assigned working groups comprising four to five members.

View Article and Find Full Text PDF

Purpose: Opioid-induced constipation (OIC) is problematic for patients with cancer receiving opioid therapy. Some guidelines recommend initiating regular laxatives at the same time as opioid analgesics. However, the effectiveness of prophylactic laxatives on OIC has not been widely demonstrated.

View Article and Find Full Text PDF

Objectives: In this study, we aimed to compare the efficacy of two regional anesthesia methods, transversus abdominis plane (TAP) block and erector spinae plane (ESP) block, for intraoperative and postoperative pain relief in patients undergoing laparoscopic nephrectomy.

Methods: Fifty patients aged 18-80 years with American Society of Anesthesiologists (ASA) classification I-II scheduled for elective laparoscopic nephrectomy were included after ethical approval and informed consent. Patients were randomly assigned to either Group TAP (receiving TAP block) or Group ESP (receiving ESP block).

View Article and Find Full Text PDF

Background: Tetrahydrocannabinol (THC)-based and cannabidiol (CBD)-based products are increasing in popularity for the management of pain. Cannabis-based products may serve as a valuable alternative to traditional analgesics such as opioids for pain management among orthopedic patients. The purpose of this study was to investigate the perspective of orthopedic sports medicine patients regarding the use of THC- and CBD-based products for the management of musculoskeletal pain.

View Article and Find Full Text PDF

BACKGROUND Butorphanol, an opioid receptor agonist and antagonist, is widely used for post-cesarean section analgesia in the form of intravenous or intramuscular injection, but nasal sprays are less used. This study aimed to evaluate the analgesic effect of butorphanol nasal spray on uterine contraction pain after cesarean section and explore its effect on postpartum prolactin secretion. MATERIAL AND METHODS We randomly divided 120 patients scheduled for cesarean section into 3 groups (40 per group): intranasal saline (control), butorphanol intranasal (BI), and butorphanol pumped intravenously (BV).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!